Head to Head Contrast: Lee Pharmaceuticals (OTCMKTS:LPHM) vs. Haleon (NYSE:HLN)

Lee Pharmaceuticals (OTCMKTS:LPHM) and Haleon (NYSE:HLN) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Valuation & Earnings

This table compares Lee Pharmaceuticals and Haleon’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lee Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
Haleon	$14.05 billion	2.61	$1.30 billion	$0.28	28.66

Haleon has higher revenue and earnings than Lee Pharmaceuticals.

Profitability

This table compares Lee Pharmaceuticals and Haleon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lee Pharmaceuticals	N/A	N/A	N/A
Haleon	9.28%	12.55%	6.13%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Lee Pharmaceuticals and Haleon, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lee Pharmaceuticals	0	0	0	0	N/A
Haleon	0	2	2	0	2.50

Risk and Volatility

Lee Pharmaceuticals has a beta of 669.91, suggesting that its share price is 66,891% more volatile than the S&P 500. Comparatively, Haleon has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.

Insider & Institutional Ownership

6.7% of Haleon shares are held by institutional investors. 55.0% of Lee Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Haleon beats Lee Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

About Lee Pharmaceuticals

Lee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.